𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detecting and describing heterogeneity in meta-analysis

✍ Scribed by Rebecca J. Hardy; Simon G. Thompson


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
279 KB
Volume
17
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Detecting and adjusting for small-study
✍ Gerta RΓΌcker; James R. Carpenter; Guido Schwarzer πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 362 KB πŸ‘ 2 views

## Abstract Publication bias and related types of small‐study effects threaten the validity of systematic reviews. The existence of small‐study effects has been demonstrated in empirical studies. Small‐study effects are graphically diagnosed by inspection of the funnel plot. Though observed funnel

Heterogeneity testing in meta-analysis o
✍ Elias Zintzaras; John P. A. Ioannidis πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 219 KB πŸ‘ 1 views

## Abstract Genome searches for identifying susceptibility loci for the same complex disease often give inconclusive or inconsistent results. Genome Search Meta‐analysis (GSMA) is an established non‐parametric method to identify genetic regions that rank high on average in terms of linkage statisti

Explaining heterogeneity in meta-analysi
✍ Simon G. Thompson; Stephen J. Sharp πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 160 KB πŸ‘ 2 views

Exploring the possible reasons for heterogeneity between studies is an important aspect of conducting a meta-analysis. This paper compares a number of methods which can be used to investigate whether a particular covariate, with a value de"ned for each study in the meta-analysis, explains any hetero

Investigating underlying risk as a sourc
✍ Simon G. Thompson; Teresa C. Smith; Stephen J. Sharp πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 329 KB πŸ‘ 2 views

In a meta-analysis of clinical trials, an important issue is whether the treatment benefit varies according to the underlying risk of the patients in the different trials. The usual naive analyses employed to investigate this question use either the observed risk of events in the control groups, or